ReviewSeminars in hearing2019
Evaluation and Management of Patients with Diabetes and Hearing Loss.
Review in Seminars in hearing, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.
- Association between diabetes mellitus and tinnitus: A meta-analysis.Biomolecules & biomedicine · 2025Pooled it
- Hearing Health Monitoring in Adults Living with Diabetes: A Scoping Review to Inform Integrated Care Pathways.Audiology research · 2026Review
- Knowledge, Attitudes, and Practices (KAP) Regarding Diabetes-Related Hearing Loss Among Providers and Patients: A Scoping Review.Healthcare (Basel, Switzerland) · 2025Review
- Racial-Ethnic Disparities in Hearing Aid Use: Price Responsiveness Among Older Adults with Hearing Loss.Journal of racial and ethnic health disparities · 2025Article
- Hearing Care Within Diabetes Care: Strategies for Direct Inclusion.Clinical diabetes : a publication of the American Diabetes Association · 2025Article
- A bidirectional Mendelian randomisation study to evaluate the relationship between body constitution and hearing loss.Scientific reports · 2023Article
- Jackson Heart Study: Aggregate cardiovascular disease risk and auditory profiles.Laryngoscope investigative otolaryngology · 2023Article
- New horizons in holistic, person-centred health promotion for hearing healthcare.Age and ageing · 2023Article
- Detecting Cochlear Synaptopathy Through Curvature Quantification of the Auditory Brainstem Response.Frontiers in cellular neuroscience · 2022Article
- Baseline audiological profiling of South African females with cervical cancer: an important attribute for assessing cisplatin-associated ototoxicity.BMC women's health · 2021Article
- Role of the Stria Vascularis in the Pathogenesis of Sensorineural Hearing Loss: A Narrative Review.Frontiers in neuroscience · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes mellitus is a significant risk factor for acquired hearing loss and tinnitus. Persons with diabetes (PWD) may present with hearing loss symptoms earlier in life than those without diabetes. Furthermore, diabetes may exacerbate risk for hearing loss related to noise exposure and ototoxic drugs. The purpose of this article is to provide recommendations for the prevention, screening, evaluation, and management of hearing loss in PWD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.